ArticleVaccines2021

High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events.

Evangelos Terpos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.